Blog
Many sponsors underestimate how much support the Food and Drug Administration (FDA) can offer ...
download
Historically, oncology drug development followed a straightforward principle: identify the highest ...
Webinar Video Replay
Watch the webinar with SubjectWell to get acceleration strategies
Gabriela Rosu, M.D., Vice President, Global Medical Affairs and Pharmacovigilance at Veristat, ...
Stay updated with Veristat's May 2025 FDA guidance and regulatory news, including new drug ...
The regulatory landscape for cell and gene therapies (CGTs) is shifting fast.
Case Study
Partner with Veristat to future-proof your early-phase rare disease trial with expert data ...
While the publishing journey can vary depending on your therapy’s requirements, Veristat’s ...
The FDA recently released a draft guidance on the use of multi-regional clinical trials (MRCTs) in ...